The Top 50 Medical Journals: Impact Factor, Readership, Prestige, and Publishing Insights (2026 Edition)
The journal with the highest Impact Factor is not necessarily the most influential place to publish a medical paper. A journal's standing also comes from who reads it, how long it has shaped its field, how often its research changes clinical practice, and how far important papers travel beyond academic publishing.
This ranking therefore combines citation impact with broader scientific and clinical influence. It considers readership and international reach, along with historical reputation. Visibility in clinical guidelines and the medical or general press also contributes to the ranking.
The result is intended as a practical guide for researchers deciding where their work would have the greatest scientific and professional impact, rather than a simple league table based on one metric. Choosing the right journal is only one part of the publication process. Researchers who need support developing, editing, or preparing a manuscript for submission can also explore my medical writing services.
1. The New England Journal of Medicine (NEJM)
Focus: General medicine and clinical research, with an emphasis on studies that can substantially influence medical practice.
Impact Factor: 84.5
Website: The New England Journal of Medicine
Readership: NEJM is read by physicians, medical researchers, health care professionals, and clinical leaders worldwide. More than 1 million people in nearly every country read NEJM in print or online each week, giving it exceptional reach within clinical medicine.
What it publishes: Major original clinical research, particularly randomized clinical trials and other definitive studies. NEJM also publishes reviews, clinical cases, perspectives, health policy research, and work addressing health care delivery.
Difficulty to publish: Extremely difficult. NEJM receives more than 16,000 submissions each year, and only about 5% of original research submissions are published. Strong methodology alone is rarely enough. A study generally needs to answer an important clinical question and represent a substantial advance.
Why submit your paper here? NEJM is the premier target when results could change clinical practice or substantially alter how an important disease is understood or treated. Few journals provide comparable recognition among clinicians worldwide.
Best suited for: Pivotal clinical trials, major therapeutic advances, definitive comparative-effectiveness studies, and other practice-changing clinical research.
2. The Lancet
Focus: General and clinical medicine with a particularly strong international perspective. Global health and public-health policy are central parts of its identity.
Impact Factor: 109.0
Website: The Lancet
Readership: The Lancet reaches clinicians, researchers, public-health professionals, policymakers, and health-system leaders around the world. Its influence is unusually international and extends well beyond academic medicine into government, global health organizations, and mainstream media.
What it publishes: Major clinical trials, observational studies, epidemiological research, systematic evidence, global-health research, health-policy work, reviews, and major Lancet Commissions.
Difficulty to publish: Extremely difficult. The journal looks for work with implications extending beyond a narrow specialty or local health system. Strong science can still be rejected if the larger clinical or public-health significance is limited.
Why submit your paper here? The Lancet is particularly attractive when a study has international implications or could influence health policy and guidelines across countries. It can be an especially strong home for major global-health and population-health research.
Best suited for: Practice-changing trials, large international studies, major epidemiological research, global-health research, and studies with substantial policy implications.
3. JAMA
Focus: General medicine, clinical research, public health, and health policy with relevance across medical specialties.
Impact Factor: 65.4
Website: JAMA
Readership: JAMA reaches physicians, researchers, health professionals, policymakers, journalists, and other readers interested in medicine worldwide. It receives more than 86 million article views and downloads annually, while more than 3.1 million people receive its electronic alerts.
What it publishes: Original Investigations, randomized trials, observational and epidemiological studies, systematic reviews, meta-analyses, Research Letters, Clinical Reviews, health-services research, and health-policy work.
Difficulty to publish: Extremely difficult. Only about 4% of research manuscripts are accepted. Successful studies usually need both rigorous methodology and relevance beyond one subspecialty.
Why submit your paper here? JAMA offers exceptional visibility in US medicine while maintaining substantial international reach. It is particularly well suited to research that connects clinical medicine with population health or health-system questions.
Best suited for: Major clinical studies, randomized trials, large cohort studies, diagnostic research, health-services research, and public-health studies.
4. The BMJ
Focus: General medicine with strong emphasis on evidence-based practice, public health, health systems, research methods, and health policy.
Impact Factor: 55.1
Website: The BMJ
Readership: The BMJ has an international audience of clinicians, researchers, health-service leaders, policymakers, and journalists. Its articles regularly enter public debates about health care and are frequently cited in policy documents and clinical guidance.
What it publishes: Original clinical and population research, randomized and pragmatic trials, observational studies, systematic reviews, Research Methods and Reporting articles, Analysis pieces, editorials, and educational material.
Difficulty to publish: Extremely difficult. The BMJ reports an overall acceptance rate of about 6%. Editorial screening is stringent, particularly for original research.
Why submit your paper here? The BMJ is especially attractive when a rigorous study has implications for how medicine is practiced or health care is organized. It is more receptive than some elite general journals to strong negative results when the research question is important.
Best suited for: Pragmatic trials, comparative-effectiveness studies, health-services research, epidemiology, public health, systematic evidence, and research methodology.
5. Nature Medicine
Focus: Translational and clinical medicine connecting biological discovery with human disease.
Impact Factor: 52.5
Website: Nature Medicine
Readership: Nature Medicine is read by biomedical researchers, physician-scientists, clinical investigators, biotechnology and pharmaceutical scientists, and researchers working at the interface between laboratory and clinical medicine.
What it publishes: Translational research, human disease mechanisms, clinical trials, biomarker studies, precision medicine, genomic medicine, therapeutic development, digital medicine, and population-health research.
Difficulty to publish: Extremely difficult. Editors look for originality and broad biomedical significance, not simply technically strong work. The strongest papers generally connect a major biological insight with convincing human relevance.
Why submit your paper here? Nature Medicine is particularly valuable when the story sits between basic science and clinical practice. It can provide more scientific depth than a traditional clinical journal while still reaching a broad medical audience.
Best suited for: Translational research, novel therapeutics, biomarkers, precision medicine, human disease mechanisms, and innovative clinical or medical technologies.
6. Journal of Clinical Oncology (JCO)
Focus: Clinical oncology and cancer research with direct implications for patient care.
Impact Factor: 44.7
Website: Journal of Clinical Oncology
Readership: JCO is read by practicing oncologists, cancer researchers, trainees, and allied health professionals worldwide. The journal recorded approximately 15 million full-text views in 2025.
What it publishes: Clinical trials, treatment studies, biomarker research, molecular oncology, supportive care, prevention, survivorship, quality-of-life research, and major studies across individual tumor types.
Difficulty to publish: Extremely difficult. JCO prioritizes research with clear clinical significance. A technically strong oncology study can still struggle if it is unlikely to alter treatment or substantially advance the field.
Why submit your paper here? For major oncology research, JCO reaches the practicing cancer community more directly than almost any other journal. Publication can rapidly place findings in front of clinicians who make treatment decisions.
Best suited for: Phase II and III trials, practice-changing oncology studies, clinically actionable biomarkers, major outcomes studies, and important tumor-specific research.
7. Circulation
Focus: Cardiovascular medicine spanning clinical practice, translational science, epidemiology, and cardiovascular disease mechanisms.
Impact Factor: 41.3
Website: Circulation
Readership: Circulation reaches cardiologists, cardiovascular researchers, academic physicians, and clinicians involved in cardiovascular prevention and treatment. Its long association with the American Heart Association gives it substantial visibility in cardiovascular medicine.
What it publishes: Major cardiovascular trials, observational studies, epidemiology, outcomes research, translational science, and research on cardiovascular mechanisms and therapeutics.
Difficulty to publish: Extremely difficult. Manuscripts need to offer more than subspecialty novelty. Editors generally look for findings with implications for a broad cardiovascular audience.
Why submit your paper here? Circulation combines exceptionally high scientific standing with strong recognition among practicing cardiologists. It is particularly valuable when findings could influence cardiovascular practice or future guidelines.
Best suited for: Major cardiovascular trials, large cohort studies, outcomes research, epidemiology, and clinically important translational research.
8. European Heart Journal
Focus: Cardiovascular medicine with a strong international clinical and scientific perspective.
Impact Factor: 45.6
Website: European Heart Journal
Readership: As the flagship journal of the European Society of Cardiology, EHJ reaches a large worldwide cardiovascular audience. It recorded approximately 17 million downloads in 2024. Its work is regularly covered by major international news organizations.
What it publishes: Original cardiovascular research, major clinical studies, trials, state-of-the-art reviews, and ESC clinical guidelines.
Difficulty to publish: Extremely difficult. The journal competes for internationally important cardiovascular research and expects both rigorous science and substantial clinical relevance.
Why submit your paper here? EHJ offers exceptional international reach and direct exposure to the European and global cardiology communities. The connection with ESC guidelines further strengthens its clinical influence.
Best suited for: Major cardiovascular trials, international studies, guideline-relevant research, cardiovascular epidemiology, and important translational studies.
9. The Lancet Oncology
Focus: Clinical oncology, cancer prevention and treatment, global oncology, and cancer policy.
Impact Factor: 33.7
Website: The Lancet Oncology
Readership: The journal reaches oncologists, cancer researchers, policymakers, public-health specialists, and health-system leaders internationally.
What it publishes: Practice-changing oncology trials, major observational research, systematic evidence, reviews, policy research, and work addressing cancer control and care internationally.
Difficulty to publish: Extremely difficult. The Lancet Oncology competes for pivotal trials and other studies capable of affecting cancer practice. Novelty and international relevance are major considerations.
Why submit your paper here? It is especially attractive when oncology research has implications beyond a single country or treatment setting. Its Lancet identity also gives important work substantial policy and media exposure.
Best suited for: Pivotal cancer trials, international treatment studies, global oncology research, cancer policy, and clinically influential evidence synthesis.
10. The Lancet Neurology
Focus: Clinical neurology, neurological disease, global neurological health, and translational neuroscience with clear clinical relevance.
Impact Factor: 54.6
Website: The Lancet Neurology
Readership: The Lancet Neurology reaches neurologists, neuroscientists, subspecialists, clinical researchers, and health-policy professionals worldwide.
What it publishes: Major clinical studies, trials, systematic reviews, neurological epidemiology, global neurological health research, and authoritative reviews across major neurological disorders.
Difficulty to publish: Extremely difficult. The journal looks for findings capable of influencing neurological practice or substantially changing understanding of an important disorder.
Why submit your paper here? It provides one of the strongest combinations of specialty prestige and international visibility available in neurology.
Best suited for: Major neurological trials, disease-modifying therapies, large cohort studies, global neurology, and clinically important neurological research.
11. Annals of Internal Medicine
Focus: Internal medicine, evidence-based clinical practice, health care, and research relevant to practicing physicians.
Impact Factor: 17.3
Website: Annals of Internal Medicine
Readership: Annals receives more than 1 million page views each month and substantial coverage in the general media. It is one of the most widely recognized general internal medicine journals.
What it publishes: Clinical trials, systematic reviews, diagnostic research, comparative-effectiveness studies, epidemiology, methodological work, and clinical guidance.
Difficulty to publish: Extremely difficult. The journal expects rigorous evidence with clear relevance to physicians working across internal medicine.
Why submit your paper here? Annals is an excellent destination for clinically important work that deserves broad physician exposure but may not require the worldwide headline significance expected by NEJM, JAMA, or The Lancet.
Best suited for: Internal-medicine trials, comparative-effectiveness research, evidence synthesis, diagnostic studies, and clinically applicable epidemiology.
12. Journal of the American College of Cardiology (JACC)
Focus: Clinical and translational cardiovascular medicine.
Impact Factor: 22.3
Website: JACC
Readership: JACC is read internationally by cardiologists, cardiovascular scientists, policymakers, and other professionals involved in cardiovascular care.
What it publishes: Clinical trials, observational studies, cardiovascular imaging and diagnostics, outcomes research, translational work, guidelines, expert panels, reviews, and Research Letters.
Difficulty to publish: Extremely difficult. JACC is one of cardiology's flagship journals. Studies must generally provide an important clinical or scientific advance rather than an incremental finding.
Why submit your paper here? JACC provides direct access to a very large clinical cardiology audience and has exceptional name recognition within the specialty.
Best suited for: Cardiovascular trials, imaging research, interventions, outcomes research, large observational studies, and clinically important translational work.
13. Journal of Hepatology
Focus: Liver disease spanning basic science, translational research, and clinical hepatology.
Impact Factor: 40.1
Website: Journal of Hepatology
Readership: As the flagship journal of the European Association for the Study of the Liver, it reaches hepatologists, gastroenterologists, liver researchers, transplant specialists, and clinical investigators worldwide.
What it publishes: Original laboratory, translational, and clinical studies in liver disease, alongside authoritative reviews and scientific correspondence.
Difficulty to publish: Extremely difficult. The Journal of Hepatology looks for originality and work capable of advancing the field internationally.
Why submit your paper here? It is one of the most prestigious destinations specifically devoted to liver research and provides exceptional visibility within international hepatology.
Best suited for: Major liver trials, viral hepatitis, MASLD and MASH research, cirrhosis, liver cancer, transplantation, biomarkers, and translational hepatology.
14. Gastroenterology
Focus: Gastrointestinal and liver disease across basic, translational, and clinical research.
Impact Factor: 29.7
Website: Gastroenterology
Readership: As the flagship journal of the American Gastroenterological Association, Gastroenterology reaches gastroenterologists, hepatologists, digestive-disease researchers, and physician-scientists internationally.
What it publishes: Original research involving the gastrointestinal tract, liver, pancreas, and biliary system. It spans mechanisms of disease through major clinical studies.
Difficulty to publish: Very difficult. Gastroenterology is one of the dominant research journals in its field and expects findings with broad relevance to digestive disease.
Why submit your paper here? The journal provides both basic-science credibility and strong exposure among clinical gastroenterologists.
Best suited for: Major GI studies, translational digestive-disease research, clinical trials, liver and pancreatic research, and mechanistic studies with clinical relevance.
15. Radiology
Focus: Medical imaging, diagnostic radiology, interventional imaging, and imaging technology.
Impact Factor: 17.6
Website: Radiology
Readership: Radiology reaches radiologists, imaging scientists, medical physicists, and other specialists worldwide through the Radiological Society of North America.
What it publishes: Clinically relevant imaging research, diagnostic studies, new imaging techniques, artificial intelligence applications, experimental research, reviews, and expert commentary.
Difficulty to publish: Very difficult. The journal expects strong methodology and a meaningful advance in imaging rather than a local validation study with limited implications.
Why submit your paper here? Radiology has exceptional authority within medical imaging and can bring new diagnostics or technologies rapidly to the attention of the field.
Best suited for: Imaging trials, diagnostic performance research, AI in imaging, novel technologies, and clinically significant radiological research.
16. Diabetes Care
Focus: Diabetes treatment, prevention, complications, epidemiology, and clinical care.
Impact Factor: 22.6
Website: Diabetes Care
Readership: Diabetes Care is aimed at physicians, clinical researchers, epidemiologists, diabetes educators, and other professionals involved in diabetes management.
What it publishes: Human clinical research involving diabetes treatment, technologies, complications, epidemiology, health services, cardiovascular and metabolic risk, psychosocial care, and nutrition.
Difficulty to publish: Very difficult. Studies need clear relevance to diabetes care and generally require substantial clinical or population-level importance.
Why submit your paper here? It is one of the most visible places for research that could affect how diabetes is managed in everyday practice.
Best suited for: Diabetes trials, continuous glucose monitoring and technology research, epidemiology, cardiovascular risk, complications, and health-services studies.
17. American Journal of Respiratory and Critical Care Medicine (AJRCCM)
Focus: Pulmonary medicine, critical care, and clinically relevant respiratory science.
Impact Factor: 21.7
Website: AJRCCM
Readership: AJRCCM has a worldwide audience of respiratory physicians, intensive-care specialists, researchers, and policymakers.
What it publishes: Clinical trials, respiratory disease research, critical-care studies, translational work, guidelines, and major reviews.
Difficulty to publish: Very difficult. The journal prioritizes innovative studies with clear implications for pulmonary or critical-care medicine.
Why submit your paper here? It is one of the strongest destinations for work capable of influencing respiratory or intensive-care practice.
Best suited for: COPD, asthma, interstitial lung disease, pulmonary vascular disease, respiratory infection, critical-care trials, and sleep-related research.
18. American Journal of Psychiatry
Focus: Psychiatry, mental health, psychiatric treatment, and clinically relevant neuroscience.
Impact Factor: 15.9
Website: American Journal of Psychiatry
Readership: AJP reaches psychiatrists, mental-health researchers, neuroscientists, psychologists, and other professionals worldwide.
What it publishes: Clinical trials, psychiatric epidemiology, treatment research, neuroscience, genetics, imaging, and studies of major psychiatric disorders.
Difficulty to publish: Very difficult. Papers need to address questions with substantial implications for psychiatric science or clinical practice.
Why submit your paper here? Few journals combine comparable history, clinical recognition, and influence across the psychiatric community.
Best suited for: Major psychiatric trials, treatment studies, large cohorts, psychiatric neuroscience, genetics, and clinically relevant epidemiology.
19. Journal of Clinical Investigation (JCI)
Focus: Mechanistic and translational biomedical research relevant to human disease.
Impact Factor: 14.3
Website: Journal of Clinical Investigation
Readership: JCI is read by physician-scientists and biomedical researchers across many specialties, particularly investigators interested in mechanisms of human disease.
What it publishes: Experimental and translational studies involving disease mechanisms, immunology, metabolism, cancer, genetics, cardiovascular disease, neuroscience, and other areas of human biology.
Difficulty to publish: Very difficult. Strong mechanistic depth is expected. Studies normally need to reveal something important about human disease rather than simply describe an association.
Why submit your paper here? JCI carries substantial prestige within academic medicine and is particularly valuable for research bridging laboratory discovery and clinical disease.
Best suited for: Mechanistic human research, translational studies, disease biology, experimental therapeutics, and physician-scientist research.
20. Hepatology
Focus: Liver disease and hepatology across clinical, translational, and experimental research.
Impact Factor: 18.0
Website: Hepatology
Readership: As a leading journal associated with the American Association for the Study of Liver Diseases, Hepatology reaches hepatologists, gastroenterologists, liver researchers, and transplant specialists internationally.
What it publishes: Clinical and laboratory research involving viral hepatitis, fatty liver disease, cirrhosis, liver cancer, transplantation, liver biology, and emerging therapies.
Difficulty to publish: Very difficult. The journal expects substantial novelty and relevance across hepatology rather than a narrowly incremental finding.
Why submit your paper here? Hepatology provides exceptional recognition within the North American and international liver communities.
Best suited for: Liver disease trials, hepatocellular carcinoma, MASH and MASLD, viral hepatitis, fibrosis, transplantation, and translational liver research.
21. Pediatrics
Focus: Pediatric medicine, child health, and clinical practice.
Impact Factor: 6.4
Website: Pediatrics
Readership: Pediatrics is read by pediatricians, child-health researchers, subspecialists, and health professionals worldwide. Its connection with the American Academy of Pediatrics gives it unusually strong clinical reach for a pediatric journal.
What it publishes: Original pediatric research, population-health studies, clinical trials, policy research, health-services work, and research addressing child and adolescent health.
Difficulty to publish: Very difficult. The Impact Factor understates the journal's standing within pediatrics. Editors look for studies likely to be relevant to a broad pediatric audience rather than one narrow subspecialty.
Why submit your paper here? For research with direct implications for pediatric practice or child-health policy, Pediatrics provides access to one of the largest and most recognizable audiences in the field.
Best suited for: General pediatric research, child-health epidemiology, prevention, health services, clinical trials, and pediatric policy.
22. PLOS Medicine
Focus: Clinical medicine, public health, global health, and research with implications for health policy.
Impact Factor: 9.9
Website: PLOS Medicine
Readership: PLOS Medicine is fully open access and reaches clinicians, researchers, policymakers, public-health professionals, and readers in settings where subscription access can be a barrier.
What it publishes: Clinical research, epidemiology, global-health studies, health-policy research, systematic evidence, and meta-research examining how medical science itself is conducted.
Difficulty to publish: Very difficult. Editors emphasize both methodological strength and the potential to inform clinical practice or public policy.
Why submit your paper here? Open access can substantially expand international reach. The journal is particularly strong when research addresses major population-health problems or inequities.
Best suited for: Global health, public health, large epidemiological studies, policy research, clinical research with broad societal implications, and meta-research.
23. Journal of the American Academy of Dermatology (JAAD)
Focus: Dermatology and the diagnosis, treatment, and epidemiology of skin disease.
Impact Factor: 12.3
Website: Journal of the American Academy of Dermatology
Readership: JAAD reaches dermatologists and dermatology researchers worldwide. The American Academy of Dermatology has more than 21,500 physician members, giving the journal substantial reach within clinical dermatology.
What it publishes: Clinical studies, therapeutic research, epidemiology, dermatologic surgery, diagnostic research, guidelines, reviews, and translational work.
Difficulty to publish: Very difficult. As the leading clinical dermatology journal, JAAD receives substantial competition for studies with clear implications for dermatologic practice.
Why submit your paper here? It offers direct exposure to one of the largest professional dermatology communities and exceptionally strong recognition within the specialty.
Best suited for: Major dermatology trials, treatment studies, epidemiology, diagnostic studies, guidelines, and clinically relevant translational research.
24. Journal of Experimental Medicine (JEM)
Focus: Immunology, cell biology, infectious disease, cancer, and mechanisms of human disease.
Impact Factor: 11.6
Website: Journal of Experimental Medicine
Readership: JEM is read primarily by immunologists, cell biologists, translational scientists, infectious-disease researchers, and investigators studying disease mechanisms.
What it publishes: Mechanistic research spanning immunology, infection, cancer biology, inflammation, neuroscience, and other areas where fundamental biology connects to disease.
Difficulty to publish: Very difficult. JEM expects mechanistic depth and biological novelty. Descriptive studies generally need compelling functional evidence to compete.
Why submit your paper here? The journal has a long history and strong reputation for foundational research that later shapes clinical and translational medicine.
Best suited for: Immunology, disease mechanisms, host-pathogen biology, cancer immunology, inflammation, and mechanistically deep translational studies.
25. Journal of Allergy and Clinical Immunology (JACI)
Focus: Allergy, immunology, asthma, immune-mediated disease, and clinical immunology.
Impact Factor: 11.7
Website: Journal of Allergy and Clinical Immunology
Readership: JACI reaches allergists, clinical immunologists, pulmonologists, immunology researchers, and clinicians treating allergic and immune-mediated diseases.
What it publishes: Clinical trials, immunological mechanisms, asthma and allergy research, biologic therapies, biomarkers, epidemiology, and translational studies.
Difficulty to publish: Very difficult. JACI is one of the dominant specialty journals in allergy and clinical immunology. Research generally needs to move understanding or treatment beyond an incremental observation.
Why submit your paper here? It combines a highly targeted clinical audience with substantial scientific credibility in immunology.
Best suited for: Asthma, food allergy, atopic disease, immunotherapy, biologics, immune mechanisms, biomarkers, and clinical immunology.
26. Annals of Surgery
Focus: Surgery, surgical science, outcomes, and innovations in clinical practice.
Impact Factor: 7.4
Website: Annals of Surgery
Readership: Annals of Surgery has a large international surgical audience and is one of the most historically respected journals in operative medicine.
What it publishes: Major surgical trials, comparative studies, outcomes research, health-services research, new operative techniques, and clinically relevant surgical science.
Difficulty to publish: Very difficult. Its Impact Factor does not fully reflect its prestige within surgery. The journal looks for evidence likely to affect surgical practice rather than small technical series.
Why submit your paper here? Publication carries considerable weight among academic surgeons and can strongly influence uptake of new operative strategies.
Best suited for: Surgical trials, large outcomes studies, comparative effectiveness, major procedural innovations, and practice-changing surgical research.
27. Clinical Gastroenterology and Hepatology (CGH)
Focus: Clinical gastroenterology and hepatology with an emphasis on patient management.
Impact Factor: 16.2
Website: Clinical Gastroenterology and Hepatology
Readership: CGH is aimed primarily at practicing gastroenterologists and hepatologists and is the clinically focused journal of the American Gastroenterological Association.
What it publishes: Clinical trials, diagnostic studies, epidemiology, comparative effectiveness, treatment outcomes, clinical reviews, and research directly applicable to digestive-disease care.
Difficulty to publish: Very difficult. Research must usually offer a clear clinical message and relevance beyond a highly specialized patient population.
Why submit your paper here? CGH can be a better choice than a more laboratory-oriented GI journal when the primary value of a study lies in patient management or clinical decision-making.
Best suited for: Clinical GI trials, outcomes research, diagnostic studies, real-world evidence, hepatology, and practice-focused research.
28. Journal of the American Society of Nephrology (JASN)
Focus: Kidney disease, nephrology, dialysis, transplantation, and renal biology.
Impact Factor: 9.7
Website: Journal of the American Society of Nephrology
Readership: JASN reaches nephrologists, kidney researchers, transplant specialists, dialysis professionals, and physician-scientists internationally.
What it publishes: Clinical nephrology, epidemiology, kidney genetics, transplantation, dialysis, hypertension, renal physiology, immunology, pathology, and basic renal science.
Difficulty to publish: Very difficult. JASN is a flagship nephrology journal and seeks research that communicates an important advance in the field.
Why submit your paper here? It offers exceptional credibility among kidney specialists and is suitable for both major clinical research and mechanistically strong renal science.
Best suited for: CKD, dialysis, transplantation, renal genetics, glomerular disease, hypertension, kidney epidemiology, and translational nephrology.
29. Molecular Psychiatry
Focus: Biological mechanisms of psychiatric disorders and their treatment.
Impact Factor: 10.4
Website: Molecular Psychiatry
Readership: Molecular Psychiatry recorded more than 11 million downloads in 2025, reflecting a substantial international audience across psychiatry and neuroscience.
What it publishes: Molecular and cellular psychiatry, genetics, imaging, biomarkers, psychopharmacology, translational neuroscience, observational studies, and selected clinical trials.
Difficulty to publish: Very difficult. Studies need a strong biological contribution rather than simply an association with a psychiatric phenotype.
Why submit your paper here? It provides high visibility for work linking psychiatric disease with genetics, neuroscience, biomarkers, or molecular mechanisms.
Best suited for: Psychiatric genetics, biomarkers, neuroimaging, molecular mechanisms, psychopharmacology, and translational mental-health research.
30. Journal of Neurology, Neurosurgery & Psychiatry (JNNP)
Focus: Clinical neurology, neurosurgery, neuropsychiatry, and neurological disease.
Impact Factor: 7.5
Website: Journal of Neurology, Neurosurgery & Psychiatry
Readership: JNNP is read internationally by neurologists, neurosurgeons, psychiatrists, neuroscientists, and neurological subspecialists.
What it publishes: Original clinical research, short reports, reviews, editorials, and studies involving stroke, multiple sclerosis, Parkinson's disease, epilepsy, neuropathy, dementia, and other neurological disorders.
Difficulty to publish: Very difficult. The journal is highly selective and looks for clinically important work relevant beyond one neurological subspecialty.
Why submit your paper here? JNNP has exceptional name recognition within clinical neuroscience and bridges neurology with neurosurgery and psychiatry more effectively than many narrower journals.
Best suited for: Major neurological cohort studies, treatment research, biomarkers, neurodegenerative disease, MS, stroke, epilepsy, and clinically oriented neuroscience.
31. CHEST
Focus: Pulmonary medicine, critical care, sleep medicine, and chest disease.
Impact Factor: 9.8
Website: CHEST
Readership: CHEST reaches pulmonologists, critical-care physicians, sleep specialists, thoracic clinicians, and multidisciplinary teams involved in chest medicine.
What it publishes: Original clinical research, trials, observational studies, guidelines, consensus statements, reviews, and clinically oriented research across pulmonary and critical-care medicine.
Difficulty to publish: Very difficult. The reported acceptance rate is approximately 15%, and the clinical significance of the research is a major editorial consideration.
Why submit your paper here? CHEST is particularly valuable when the goal is to reach practicing pulmonary and critical-care clinicians rather than a predominantly laboratory audience.
Best suited for: COPD, asthma, lung cancer, pulmonary vascular disease, sleep medicine, respiratory infection, and critical-care research.
32. Anesthesiology
Focus: Anesthesiology, perioperative medicine, critical care, and pain medicine.
Impact Factor: 9.4
Website: Anesthesiology
Readership: As the official journal of the American Society of Anesthesiologists, it reaches anesthesiologists, perioperative physicians, pain specialists, critical-care clinicians, and researchers internationally.
What it publishes: Clinical trials, perioperative outcomes research, anesthetic pharmacology, monitoring, patient safety, pain research, critical-care studies, and mechanistic investigations relevant to anesthesia.
Difficulty to publish: Very difficult. The journal emphasizes methodological rigor and research capable of changing clinical practice or advancing fundamental understanding of anesthesiology.
Why submit your paper here? It is one of the most recognizable and authoritative publication venues in the specialty.
Best suited for: Perioperative trials, anesthesia safety, pain research, pharmacology, monitoring technologies, and clinically relevant mechanistic studies.
33. Ophthalmology
Focus: Clinical ophthalmology, eye disease, surgery, diagnostics, and vision care.
Impact Factor: 10.9
Website: Ophthalmology
Readership: Ophthalmology reaches practicing ophthalmologists, ophthalmic surgeons, vision researchers, and subspecialists worldwide through its association with the American Academy of Ophthalmology.
What it publishes: Clinical trials, surgical outcomes, diagnostic research, ophthalmic imaging, epidemiology, treatment studies, and major reviews.
Difficulty to publish: Very difficult. The journal looks for work capable of influencing ophthalmic practice, particularly well-powered clinical studies or important diagnostic advances.
Why submit your paper here? It gives clinically relevant eye research direct exposure to a broad international ophthalmology audience.
Best suited for: Ophthalmic trials, surgical outcomes, retinal disease, glaucoma, diagnostics, imaging, and population eye-health research.
34. Arthritis & Rheumatology
Focus: Rheumatic disease, inflammatory arthritis, autoimmunity, and musculoskeletal medicine.
Impact Factor: 9.9
Website: Arthritis & Rheumatology
Readership: The journal reaches rheumatologists, immunologists, physician-scientists, and researchers studying inflammatory and autoimmune disease.
What it publishes: Clinical and translational research involving rheumatoid arthritis, lupus, inflammatory disease, osteoarthritis, autoimmunity, biomarkers, therapeutics, and disease mechanisms.
Difficulty to publish: Very difficult. As a flagship rheumatology journal, it expects strong novelty and evidence relevant to a substantial portion of the specialty.
Why submit your paper here? It combines strong clinical recognition with substantial credibility in immunology and disease mechanisms.
Best suited for: Rheumatoid arthritis, lupus, inflammatory arthritis, autoimmune mechanisms, biologics, biomarkers, and rheumatology trials.
35. Clinical Infectious Diseases (CID)
Focus: Clinical infectious disease and research capable of influencing patient care.
Impact Factor: 8.3
Website: Clinical Infectious Diseases
Readership: CID recorded more than 7.3 million full-text uses in 2025. Its audience includes infectious-disease physicians, microbiologists, epidemiologists, antimicrobial specialists, and public-health professionals.
What it publishes: Practice-changing clinical research, trials, observational studies, antimicrobial research, infections in special populations, guidelines, and reviews.
Difficulty to publish: Very difficult. CID explicitly prioritizes research capable of altering clinical practice. Routine descriptive studies face a high threshold.
Why submit your paper here? Its close connection with the Infectious Diseases Society of America gives research direct access to clinicians and guideline-oriented audiences.
Best suited for: Infectious-disease trials, antimicrobial treatment, emerging infections, epidemiology, real-world outcomes, and clinically important observational research.
36. Thorax
Focus: Respiratory medicine, pulmonary disease, and respiratory science.
Impact Factor: 9.1
Website: Thorax
Readership: Thorax reaches respiratory physicians, clinical scientists, pulmonologists, and researchers internationally. It is the journal of the British Thoracic Society.
What it publishes: Clinical and experimental research on COPD, asthma, lung cancer, respiratory infection, sleep and ventilation, occupational lung disease, and other pulmonary disorders.
Difficulty to publish: Very difficult. Its reported acceptance rate is approximately 16%, with rapid editorial screening.
Why submit your paper here? Thorax has strong international prestige and is particularly attractive for respiratory work with a clear clinical message.
Best suited for: Respiratory trials, COPD, asthma, lung cancer, respiratory epidemiology, infection, and translational pulmonary research.
37. American Journal of Obstetrics & Gynecology (AJOG)
Focus: Obstetrics, gynecology, maternal-fetal medicine, and reproductive health.
Impact Factor: 7.9
Website: American Journal of Obstetrics & Gynecology
Readership: AJOG reaches obstetricians, gynecologists, maternal-fetal medicine specialists, reproductive-health researchers, and other clinicians involved in women's health.
What it publishes: Clinical and translational research, reviews, reproductive biology, maternal and fetal disease, gynecologic disorders, prevention, diagnosis, and treatment research.
Difficulty to publish: Very difficult. AJOG expects work capable of changing understanding or practice in women's health rather than small local clinical series.
Why submit your paper here? Known as the "Gray Journal," AJOG has long-standing recognition across obstetrics and gynecology and offers strong clinical visibility.
Best suited for: Maternal-fetal medicine, pregnancy outcomes, obstetric trials, reproductive health, gynecologic disease, and translational women's-health research.
38. The Journal of Urology
Focus: Urology, genitourinary disease, surgery, and urologic oncology.
Impact Factor: 9.7
Website: The Journal of Urology
Readership: The Journal of Urology reaches urologists, urologic surgeons, oncologists, and genitourinary researchers internationally and has a long-standing relationship with the American Urological Association.
What it publishes: Clinical trials, surgical research, urologic oncology, benign urological disease, diagnostics, outcomes, epidemiology, and translational studies.
Difficulty to publish: Very difficult. The journal has a high editorial threshold for clinical relevance and expects studies to advance urologic practice.
Why submit your paper here? It is one of the best recognized names in urology and provides direct exposure to the specialty's clinical community.
Best suited for: Urologic oncology, surgery, urinary tract disease, prostate research, outcomes, diagnostics, and major urological clinical studies.
39. Journal of Clinical Endocrinology & Metabolism (JCEM)
Focus: Clinical endocrinology, diabetes, metabolism, and hormone-related disease.
Impact Factor: 5.4
Website: Journal of Clinical Endocrinology & Metabolism
Readership: JCEM recorded almost 5.9 million full-text uses in 2025 and reaches endocrinologists, metabolic researchers, and clinicians worldwide.
What it publishes: Clinical endocrine research, trials, metabolic studies, diabetes-related research, reproductive endocrinology, bone and mineral metabolism, thyroid disease, and endocrine technologies.
Difficulty to publish: Difficult. JCEM is highly established and looks for clinically relevant endocrine research with robust methods and a clear contribution to the field.
Why submit your paper here? It offers exceptionally broad exposure among practicing endocrinologists and is particularly strong for clinically oriented work.
Best suited for: Endocrine trials, thyroid disease, metabolic research, bone health, reproductive endocrinology, diabetes, and hormone-related disorders.
40. The American Journal of Clinical Nutrition (AJCN)
Focus: Human nutrition, diet, metabolism, and nutrition-related health.
Impact Factor: 7.1
Website: The American Journal of Clinical Nutrition
Readership: AJCN reaches nutrition scientists, physicians, dietitians, epidemiologists, public-health researchers, and investigators working in metabolism.
What it publishes: Nutrition trials, dietary interventions, cohort studies, nutritional epidemiology, metabolism, obesity, micronutrients, and research linking diet with chronic disease.
Difficulty to publish: Difficult. Strong study design is particularly important because the field contains many observational associations. The journal favors research that substantially advances nutritional science.
Why submit your paper here? AJCN has exceptional name recognition within nutrition and reaches both clinical and population-health audiences.
Best suited for: Nutrition trials, dietary epidemiology, metabolism, obesity, micronutrients, and clinically relevant nutritional research.
41. Journal of Bone and Joint Surgery (JBJS)
Focus: Orthopaedic surgery and musculoskeletal medicine.
Impact Factor: 4.5
Website: Journal of Bone and Joint Surgery
Readership: JBJS is read internationally by orthopaedic surgeons, musculoskeletal researchers, trainees, and other clinicians involved in bone and joint care.
What it publishes: Surgical trials, comparative studies, outcomes research, orthopaedic techniques, implant research, trauma, joint replacement, and musculoskeletal disease.
Difficulty to publish: Difficult. JBJS has a level of specialty prestige that is not captured fully by its Impact Factor. Clinically consequential research is favored over small technical reports.
Why submit your paper here? It is one of the most recognizable and historically important journals in orthopaedic surgery.
Best suited for: Orthopaedic trials, joint replacement, trauma, surgical outcomes, implant research, and clinically important musculoskeletal studies.
42. The Journal of Infectious Diseases (JID)
Focus: Infectious-disease pathogenesis, epidemiology, immunology, and translational research.
Impact Factor: 4.1
Website: The Journal of Infectious Diseases
Readership: JID recorded more than 2.6 million full-text uses in 2025. It reaches infectious-disease researchers, microbiologists, immunologists, epidemiologists, and clinician-scientists.
What it publishes: Pathogenesis, host-pathogen interactions, infectious-disease epidemiology, vaccines, immunity, antimicrobial science, and translational research.
Difficulty to publish: Difficult. JID generally expects more mechanistic or biological depth than its clinically focused sister journal CID.
Why submit your paper here? It is particularly suitable for infectious-disease research that connects laboratory science with human infection.
Best suited for: Pathogenesis, infectious-disease immunology, vaccines, virology, bacterial disease, epidemiology, and translational infection research.
43. The Journal of Immunology
Focus: Fundamental and translational immunology.
Impact Factor: 4.0
Website: The Journal of Immunology
Readership: The Journal of Immunology has served the immunology community for more than a century and reaches immunologists and biomedical researchers internationally.
What it publishes: Cellular and molecular immunology, innate and adaptive immunity, immune regulation, infection, inflammation, cancer immunology, and translational immune research.
Difficulty to publish: Difficult. The journal expects rigorous immunological work with a meaningful mechanistic contribution.
Why submit your paper here? Its historical standing and specialist recognition remain substantial even though its current Impact Factor is lower than several newer immunology journals.
Best suited for: Mechanistic immunology, immune-cell biology, infection, inflammation, cancer immunology, and translational immune research.
44. Journal of Antimicrobial Chemotherapy (JAC)
Focus: Antimicrobial therapy, resistance, pharmacology, stewardship, and infectious disease.
Impact Factor: 4.1
Website: Journal of Antimicrobial Chemotherapy
Readership: JAC recorded more than 2 million full-text uses in 2025. Its readership spans academia, industry, health services, and professionals involved in antimicrobial treatment and stewardship.
What it publishes: Antibacterial, antiviral, antifungal, and antiparasitic research, antimicrobial resistance, stewardship, pharmacokinetics, pharmacodynamics, clinical trials, and evidence synthesis.
Difficulty to publish: Difficult. Research generally needs to advance antimicrobial science or provide evidence applicable to treatment or stewardship.
Why submit your paper here? JAC has particularly strong visibility among researchers and clinicians working on antimicrobial resistance.
Best suited for: Antimicrobial resistance, stewardship, PK/PD, antibiotic treatment, antifungal and antiviral therapy, and resistance mechanisms.
45. Journal of Thoracic and Cardiovascular Surgery (JTCVS)
Focus: Cardiothoracic surgery and surgical treatment of cardiovascular and thoracic disease.
Impact Factor: 4.7
Website: Journal of Thoracic and Cardiovascular Surgery
Readership: JTCVS reaches cardiac surgeons, thoracic surgeons, interventional specialists, and cardiovascular researchers internationally.
What it publishes: Cardiac surgery, thoracic surgery, transplantation, congenital heart surgery, valve procedures, aortic surgery, surgical outcomes, and emerging operative technologies.
Difficulty to publish: Difficult. The journal favors technically strong studies with implications for cardiothoracic practice, particularly larger comparative or outcomes studies.
Why submit your paper here? It is a long-established specialty destination with direct access to the cardiothoracic surgical community.
Best suited for: Cardiothoracic procedures, valve surgery, aortic disease, thoracic oncology, transplantation, and major surgical outcomes research.
46. Journal of Neurosurgery
Focus: Neurosurgery, neurological surgery, and clinically relevant neuroscience.
Impact Factor: 3.8
Website: Journal of Neurosurgery
Readership: The Journal of Neurosurgery is read by neurosurgeons, neurological researchers, spine specialists, and other clinicians involved in operative neurological care.
What it publishes: Neurosurgical outcomes, operative techniques, neuro-oncology, cerebrovascular surgery, functional neurosurgery, trauma, spine-related research, and clinical neuroscience.
Difficulty to publish: Difficult. Its historical prestige within neurosurgery is considerably greater than its Impact Factor alone suggests. Competitive papers generally need strong clinical evidence or an important technical advance.
Why submit your paper here? It remains one of the most established names in academic neurosurgery.
Best suited for: Neurosurgical outcomes, brain tumors, cerebrovascular surgery, operative techniques, functional neurosurgery, and major clinical series.
47. Neurosurgery
Focus: Clinical neurosurgery, operative techniques, neurological disease, and surgical innovation.
Impact Factor: 3.8
Website: Neurosurgery
Readership: As a major journal associated with the Congress of Neurological Surgeons, Neurosurgery reaches practicing neurosurgeons, academic surgeons, residents, and neuroscience researchers.
What it publishes: Clinical research, surgical techniques, neuro-oncology, vascular neurosurgery, spine surgery, functional neurosurgery, outcomes, and emerging technology.
Difficulty to publish: Difficult. Manuscripts need clear relevance to neurosurgical practice and are judged heavily on methodological quality and novelty.
Why submit your paper here? The journal has strong recognition among practicing neurosurgeons and is particularly useful for clinically focused surgical research.
Best suited for: Neurosurgical trials, operative innovation, spine and cranial surgery, outcomes, neuro-oncology, and surgical technology.
48. Journal of Medical Genetics
Focus: Human genetics, genomic medicine, and genetic disease.
Impact Factor: 3.4
Website: Journal of Medical Genetics
Readership: JMG reaches clinical geneticists, genomic scientists, genetic counselors, molecular researchers, and clinicians incorporating genetics into medical practice.
What it publishes: Human genetics, germline cancer genetics, molecular causes of disease, genomic diagnostics, genotype-phenotype studies, and clinical applications of molecular genetics.
Difficulty to publish: Difficult. The journal reports an acceptance rate of approximately 15%. Research needs to offer meaningful genetic or clinical insight rather than another isolated variant report.
Why submit your paper here? JMG provides a respected bridge between genomic discovery and clinical genetics.
Best suited for: Mendelian disease, genomic diagnostics, cancer genetics, genotype-phenotype studies, human genomic research, and clinical implementation of genetics.
49. Journal of Clinical Gastroenterology
Focus: Clinical gastroenterology and practical management of digestive disease.
Impact Factor: 2.7
Website: Journal of Clinical Gastroenterology
Readership: The journal is directed primarily toward practicing gastroenterologists and clinicians who manage gastrointestinal and hepatobiliary disease.
What it publishes: Clinical studies, reviews, case-based research, technical reports, treatment recommendations, and practical articles covering gastrointestinal disease.
Difficulty to publish: Difficult. The threshold is lower than at Gastroenterology or CGH, but manuscripts still need sound methodology and a clear clinical contribution.
Why submit your paper here? It can be a realistic and reputable destination for clinically useful GI research that is too focused or incremental for the highest-ranked gastroenterology journals.
Best suited for: Clinical GI studies, treatment outcomes, practical management research, smaller clinical cohorts, and specialist reviews.
50. Journal of Pediatric Surgery
Focus: Pediatric surgery and surgical care of infants, children, and adolescents.
Impact Factor: 2.3
Website: Journal of Pediatric Surgery
Readership: The journal reaches pediatric surgeons, pediatric surgical researchers, trainees, and clinicians involved in the operative care of children.
What it publishes: Pediatric surgical outcomes, congenital anomalies, neonatal surgery, trauma, oncology, minimally invasive techniques, surgical education, and comparative clinical studies.
Difficulty to publish: Difficult. The journal operates in a smaller specialty, so its Impact Factor should not be compared directly with large fields such as cardiology or oncology. Successful studies still need sound methods and clear relevance to pediatric surgical care.
Why submit your paper here? For a paper specifically addressing pediatric surgery, the targeted audience can be more valuable than the larger citation numbers of a broader medical journal.
Best suited for: Congenital surgery, neonatal surgery, pediatric trauma, pediatric surgical oncology, operative outcomes, and new pediatric surgical techniques.
How to Use This Ranking When Choosing a Journal
The highest-ranked journal is not automatically the best journal for a particular manuscript. A specialized paper can have more clinical influence in the leading journal of its field than in a broader journal where the audience is less directly relevant.
A useful starting point is therefore to identify the journals whose readers would care most about the central finding. Then consider whether the scientific importance of the study matches the journal's editorial threshold. Impact Factor and prestige become most useful after that fit has been established.
For very strong manuscripts, authors can also build a submission sequence before the first submission. That makes it easier to move efficiently from an aspirational target to a strong specialty journal if the first journal declines the paper.
